Newbridge Financial Services Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,500
| Closed | -$13.1K | – | 1039 |
|
|
2024
Q2 | $13.1K | Hold |
36,500
| – | – | ﹤0.01% | 657 |
|
|
2024
Q1 | $24.5K | Buy |
+36,500
| New | +$24.5K | 0.01% | 556 |
|
|
2023
Q1 | – | Sell |
-2,000
| Closed | -$6.28K | – | 1469 |
|
|
2022
Q4 | $6.28K | Hold |
2,000
| – | – | ﹤0.01% | 1018 |
|
|
2022
Q3 | $10K | Sell |
2,000
-1,000
| -33% | -$5K | 0.01% | 889 |
|
|
2022
Q2 | $12K | Buy |
3,000
+1,500
| +100% | +$6K | 0.01% | 819 |
|
|
2022
Q1 | $9K | Hold |
1,500
| – | – | ﹤0.01% | 974 |
|
|
2021
Q4 | $11K | Hold |
1,500
| – | – | 0.01% | 900 |
|
|
2021
Q3 | $14K | Buy |
+1,500
| New | +$14K | 0.01% | 780 |
|